Trial intelligence / Profile preview

Lidocaine Nasal Drop vs Placebo for Nasogastric Tube Insertion Discomfort

TCTR20230704004Phase 1Completed

Sponsor
Thammasat University
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial comparing Lidocaine nasal drop with Placebo nasal drop (2 arms). Primary endpoints: Discomfort during nasogastric tube insertion and Complications of nasogastric tube insertion. Started Sep 2021; status: completed.

02

Drugs

lidocaine

Beyond the preview

Go deeper on TCTR20230704004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230704004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call